Tradestie Institutional Equity Comparison Engine

NEXR vs CMND โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CMND Overall Edge

CMND Captures Institutional Edge (2โ€“0 Pillars ยท 8โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Clearmind Medicine Inc. Common Shares (CMND) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, NEXR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CMND at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NEXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CMND sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NEXR N/M vs CMND N/M Fwd P/E
Growth & Margin Winner CMND
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner CMND
1Y -39.2% vs +1108.2% ยท 52W Pos 23% vs 58%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
NEXR US Equity
NEXR
Institutional Equity
$1.38
-7.38% 1D
Market Cap N/A
1M Return +67.27%
1Y Return -39.21%
Forward P/E N/M
Unified AI Score
31.0 / 100 SELL
Tech 50.0 Fund 27.0 Flow 50.0 Mom 40.0
CMND NASDAQ
Clearmind Medicine Inc. Common Shares
Pharmaceutical Preparations
$4.18
-7.67% 1D
Market Cap $2.3M
1M Return -33.18%
1Y Return +1108.17%
Forward P/E N/M
Unified AI Score
49.8 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NEXR -39.21% CMND +1108.17% Spread: +341.39 pp (CMND Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NEXR TTM Op. Margin: N/A CMND TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NEXR vs CMND. Trailing 12-month operating profitability (NEXR N/A vs CMND 0.0%) and valuation multiples (NEXR N/M vs CMND N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NEXR (0) vs CMND (8)
Institutional Metric NEXR CMND Criterion Row Winner
Market Capitalization Scale N/A $2.3M Larger Scale CMND
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth CMND
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin CMND
Net Profit Margin Profitability N/A 0.0% Higher Margin CMND
Return on Equity (ROE) Capital Efficiency N/A -107.0% Higher ROE CMND
52-Week Range Position Momentum 23% ($0โ€“$5) 58% ($0โ€“$7) Stronger Trend CMND
Beta / 30D Volatility Risk Regime 8.42ฮฒ ยท 2730% Vol 3.87ฮฒ ยท 58% Vol Lower Realized Risk CMND
Unified Institutional Score Composite Signal 31.0 / 100 (SELL) 49.8 / 100 (HOLD) Higher Composite CMND

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NEXR vs CMND Buy Guide
NEXR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NEXR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CMND UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CMND Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NEXR nor CMND registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.